Clinical Trials List
Protocol Number1368-0059
2021-10-15 - 2022-06-09
Phase II
Recruiting3
-
Trial Applicant
Boehringer Ingelheim
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- 施怡倫 無
- YEN-HSUAN NI 無
- 謝銘鈞 無
- 翁孟慈 無
- CHIEN-CHIH TUNG 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Hung-Hsin Lin 無
- 張世慶 無
- 姜正愷 無
- 鄭厚軒 無
- Chien-An Liu 無
- 王煥昇 無
- 黃聖捷 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- FAN -FENG CHIANG 無
- 許斯淵 未分科
- 陳家昌 無
- 許斯淵 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
2 participants
-
Global
100 participants
